SCHEMBL4367200

SCHEMBL4367200

COc1ccc(Oc2ccccc2)cc1NC(=O)c1cc(Cl)ccc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 5/20 0.60
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 1/20 0.58
HIF1A Q16665 1/20 0.58
PPARG P37231 1/20 0.56
METAP2 P50579 1/20 0.56
STK39 Q9UEW8 2/20 0.55
LMNA P02545 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MAPT P10636 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MEN1 O00255 2/20 0.54
MAPK1 P28482 2/20 0.54
KMT2A Q03164 2/20 0.54
GAA P10253 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
P2RX1 P51575 1/20 0.54
SERPINE1 P05121 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330588 0.84 ACLY (0.74) KCNMA1KDM4EALDH1A1HIF1AMETAP2
SCHEMBL13928800 0.83 KCNMA1 (0.72) KCNMA1KDM4EALDH1A1HIF1AMETAP2
SCHEMBL30692667 0.81 TMPRSS4 (0.76) KCNMA1STK39P2RX1TMPRSS4
SCHEMBL24438295 0.81 TMPRSS4 (0.76) KCNMA1STK39P2RX1TMPRSS4
SCHEMBL30081452 0.80 KMT2A (0.74) KCNMA1KDM4EALDH1A1HIF1APPARG
SCHEMBL30692657 0.80 ALDH1A1 (0.70) KCNMA1KDM4EALDH1A1STK39LMNA
SCHEMBL24438157 0.80 ALDH1A1 (0.70) KCNMA1KDM4EALDH1A1STK39LMNA
SCHEMBL1025899 0.80 KMT2A (0.74) KCNMA1KDM4EALDH1A1HIF1APPARG
SCHEMBL29528138 0.80 KMT2A (0.74) KCNMA1KDM4EALDH1A1HIF1APPARG
SCHEMBL13812698 0.79 KCNMA1 (0.51) KCNMA1KDM4EHIF1APPARGLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7547804-B2 Compounds, compositions, and methods employing same MYRIAD GENETICS, INC. (US) 2009-06-16 US disclosed
US-20050187300-A1 Compounds, compositions, and methods employing same MYRIAD GENETICS, INCORPORATED (US) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187300-A1 Compounds, compositions, and methods employing same HMGCR, APOB, PCSK9 KCNMA1 3818/4885KDM4E 4397/4885ALDH1A1 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.